News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
EBERT CHARLES D
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/08/2013 |
4
| EBERT CHARLES D (SVP, BRANDS R&D) has filed a Form 4 on Actavis plc|
Txns:
| Sold 10,877 shares
@ $158.75, valued at
$1.7M
|
|
| 10/03/2013 |
4
| EBERT CHARLES D (SVP, BRANDS R&D) has filed a Form 4 on Actavis plc|
Txns:
| Granted 18,488 shares
@ $0 |
|
| 10/03/2013 |
3
| EBERT CHARLES D (Sr. VP, Brands R & D) has filed a Form 3 on Actavis plc |
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/13/2013 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 03/08/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/07/2013 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 1,331 shares
@ $86.46, valued at
$115.1k
|
|
| 03/05/2013 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on Actavis, Inc.|
Txns:
| Paid exercise price by delivering 1,761 shares
@ $85.54, valued at
$150.6k
|
|
| 03/16/2012 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,265 shares
@ $59.21, valued at
$74.9k
|
|
| 03/12/2012 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Granted 3,342 shares
@ $0
Granted 2,566 shares
@ $0 |
|
| 03/01/2012 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 1,000 shares
@ $58.7715, valued at
$58.8k
Sold 3,981 shares
@ $58.811, valued at
$234.1k
Exercised 1,000 options to buy
@ $25.64, valued at
$25.6k
|
|
| 02/28/2012 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,458 shares
@ $58.17, valued at
$84.8k
|
|
| 06/01/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2011 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 616 shares
@ $56.89, valued at
$35k
|
|
| 03/08/2011 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,295 shares
@ $56.79, valued at
$73.5k
|
|
| 12/07/2010 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 3,639 shares
@ $51, valued at
$185.6k
|
|
| 09/02/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/16/2010 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 1,200 shares
@ $40.88, valued at
$49.1k
Sold 1,500 shares
@ $40.86, valued at
$61.3k
Sold 850 shares
@ $40.87, valued at
$34.7k
Sold 200 shares
@ $40.875, valued at
$8.2k
Sold 200 shares
@ $40.865, valued at
$8.2k
Sold 24,650 shares
@ $40.85, valued at
$1M
Paid exercise price by delivering 1,265 shares
@ $41.37, valued at
$52.3k
Exercised 1,600 options to buy
@ $38.92, valued at
$62.3k
Exercised 6,400 options to buy
@ $38.92, valued at
$249.1k
Exercised 4,843 options to buy
@ $26.14, valued at
$126.6k
Exercised 8,757 options to buy
@ $26.14, valued at
$228.9k
|
|
| 12/11/2009 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC|
Txns:
| Sold 19,000 shares
@ $38.25, valued at
$726.8k
Exercised 3 options to buy
@ $27.88, valued at
$83.6
Exercised 10,997 options to buy
@ $27.88, valued at
$306.6k
Exercised 3,838 options to buy
@ $26.4, valued at
$101.3k
Exercised 4,162 options to buy
@ $26.4, valued at
$109.9k
|
|
| 08/13/2009 |
4
| EBERT CHARLES D (Sr. VP, Research & Development) has filed a Form 4 on WATSON PHARMACEUTICALS INC |
|
|